The BMCS Mastering MedChem II: 2nd RSC-BMCS symposium on mastering medicinal chemistry
9 March, 2016, 09:00-19:00, Huddersfield, UK
14:00, "Structure-based drug discovery applied to membrane proteins" : Miles Congreve, Heptares, UK.
Frontiers in Medicinal Chemistry 2016: Mar 13-16, 2016, Bonn, Germany
March 14, 9:05, Presenting: Miles Congreve
"Discovery of a Negative Allosteric Modulator of the mGlu5 receptor by Fragment Based Drug Discovery"
251st ACS National Meeting and Exposition - Computers in Chemistry: March 13-17, 2016. San Diego, CA, USA
Presenting: Jon Mason
6th Focused Meeting on Cell Signalling: April 18-19, 2016, Leicester, UK
Presenting: Fiona Marshall
27th symposium on Medicinal Chemistry in Eastern England: 21st April 2016, Hertfordshire, UK
15.55 "Novel structure-based approaches to antagonism of Family B GPCRs"
Andrea Bortolato, Heptares
BioTrinity 2016 - Europe's Leading Investment and Biopartnering Conference, 25-27, April, 2016
27 April, 11:50-12:30 Panel: "Europe's Biggest Transactions: Dealmaking Insight from the Trenches"
Malcolm Weir, CEO, Heptares Therapeutics Ltd
6th Diabetes Partnering & Deal-Making Conference: April 25-27, 2016, Boston, MA
2016 Advisory Board Members: Dan Grau, Heptares Therapeutics
April 26, 2016, Panel: "Equity Markets and Investment Trends in Diabetes and Obesity"
3:30 Moderator: Dan Grau, President Heptares
10th Drug Design & Medicinal Chemistry Conference, May 11-12, 2016, Berlin, Germany
May 11, 2016, 18:00,
"Structure-Based Drug Design with G Protein-Coupled Receptors: The Discovery of Highly Selective M1 Agonists"
Giles Brown Director, Medicinal Chemistry, Heptares
.
European Pharma Summit 2016: Berlin, Germany. May 11-13, 2016
3rd GPCR Targeted Screening Conference: May 12-13, 2016: Scientific Advisory Board Members: Ali Jazayeri, Heptares
May 13, 13:50, Session: GPCR Structure and Dynamics
Robert Cooke Director, Biomolecular Structure, Heptares
33rd Camerino-Cyprus Symposium: Camerino, Italy, May 15-19, 2016
Receptor Chemistry: Reality and Vision: Session Title: "Modeling GPCRs in the Structural Biology Era"
"Revelations from GPCR Protein-Ligand Structures, with Key Roles for Water and the Prediction of Kinetics."
: Jonathan Mason (Heptares)
6th RSC / SCI symposium on GPCRs in Medicinal Chemistry, 13-15 June, 2016, Verona, Italy
13th 09:30
・Plenary: "The seventh millennium of GPCR drug discovery" Fiona Marshall, Heptares (UK)
14th 11:30
・Jonathan Mason,”Roles of waters to predict binding affinity, selectivity and kinetics: a key component of high end GPCR SBDD”
Takeda and Heptares are also confirmed sponsors.
Next Generation Protein Therapeutics, June 13-15, 2016, San Francisco, CA
June 14, 2016 9:15, "Recombinant GPCRs as Targets for Biopharmaceutical Development" NEW DATA
Catherine Hutchings, Ph.D., Consultant, Antibody Alliance Management & Strategic Partnering, Heptares, UK
School of Chemistry University of Leeds: Organic seminars
22/06/2016: Miles Congrev (Heptares)
Heptares Events
The BMCS Mastering MedChem II: 2nd RSC-BMCS symposium on mastering medicinal chemistry
9 March, 2016, 09:00-19:00, Huddersfield, UK
14:00, "Structure-based drug discovery applied to membrane proteins" : Miles Congreve, Heptares, UK.
Frontiers in Medicinal Chemistry 2016: Mar 13-16, 2016, Bonn, Germany
March 14, 9:05, Presenting: Miles Congreve
"Discovery of a Negative Allosteric Modulator of the mGlu5 receptor by Fragment Based Drug Discovery"
251st ACS National Meeting and Exposition - Computers in Chemistry: March 13-17, 2016. San Diego, CA, USA
Presenting: Jon Mason
6th Focused Meeting on Cell Signalling: April 18-19, 2016, Leicester, UK
Presenting: Fiona Marshall
27th symposium on Medicinal Chemistry in Eastern England: 21st April 2016, Hertfordshire, UK
15.55 "Novel structure-based approaches to antagonism of Family B GPCRs"
Andrea Bortolato, Heptares
BioTrinity 2016 - Europe's Leading Investment and Biopartnering Conference, 25-27, April, 2016
27 April, 11:50-12:30 Panel: "Europe's Biggest Transactions: Dealmaking Insight from the Trenches"
Malcolm Weir, CEO, Heptares Therapeutics Ltd
6th Diabetes Partnering & Deal-Making Conference: April 25-27, 2016, Boston, MA
2016 Advisory Board Members: Dan Grau, Heptares Therapeutics
April 26, 2016, Panel: "Equity Markets and Investment Trends in Diabetes and Obesity"
3:30 Moderator: Dan Grau, President Heptares
10th Drug Design & Medicinal Chemistry Conference, May 11-12, 2016, Berlin, Germany
May 11, 2016, 18:00,
"Structure-Based Drug Design with G Protein-Coupled Receptors: The Discovery of Highly Selective M1 Agonists"
Giles Brown Director, Medicinal Chemistry, Heptares
.
European Pharma Summit 2016: Berlin, Germany. May 11-13, 2016
3rd GPCR Targeted Screening Conference: May 12-13, 2016: Scientific Advisory Board Members: Ali Jazayeri, Heptares
May 13, 13:50, Session: GPCR Structure and Dynamics
Robert Cooke Director, Biomolecular Structure, Heptares
33rd Camerino-Cyprus Symposium: Camerino, Italy, May 15-19, 2016
Receptor Chemistry: Reality and Vision: Session Title: "Modeling GPCRs in the Structural Biology Era"
"Revelations from GPCR Protein-Ligand Structures, with Key Roles for Water and the Prediction of Kinetics."
: Jonathan Mason (Heptares)
6th RSC / SCI symposium on GPCRs in Medicinal Chemistry, 13-15 June, 2016, Verona, Italy
13th 09:30
・Plenary: "The seventh millennium of GPCR drug discovery" Fiona Marshall, Heptares (UK)
14th 11:30
・Jonathan Mason,”Roles of waters to predict binding affinity, selectivity and kinetics: a key component of high end GPCR SBDD”
Takeda and Heptares are also confirmed sponsors.
Next Generation Protein Therapeutics, June 13-15, 2016, San Francisco, CA
June 14, 2016 9:15, "Recombinant GPCRs as Targets for Biopharmaceutical Development" NEW DATA
Catherine Hutchings, Ph.D., Consultant, Antibody Alliance Management & Strategic Partnering, Heptares, UK
School of Chemistry University of Leeds: Organic seminars
22/06/2016: Miles Congrev (Heptares)
・・・
いよいよ成長の歯車も本格的に動き出し、R&Dの進展・拡大そして加速が楽しみですね。笑。